Progression of Diabetic Retinopathy in the Bevordex study: a randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema

被引：0
|
作者：
Lim, Lyndell L. [1 ,2 ]
Qatarneh, Dania [1 ]
Hodgson, Lauren [1 ]
Mehta, Hemal [3 ]
Wickremasinghe, Sanjeewa [1 ,2 ]
Campain, Anna [3 ]
Gillies, Mark C. [3 ]
Fraser-Bell, Samantha [3 ]
机构：
[1] Univ Melbourne, Ctr Eye Res Australia, East Melbourne, Vic, Australia
[2] Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia
[3] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2106
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema
    Sheth, Saumil
    Rush, Ryan
    Natarajan, Sundaram
    Gillies, Mark
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (07): : 673 - 681
  • [42] Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome
    ElBendary, Amal
    Elkannishy, Amr H.
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2018, 32 (04) : 303 - 309
  • [43] Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema
    Aroney, Christine
    Fraser-Bell, Samantha
    Lamoureux, Ecosse L.
    Gillies, Mark C.
    Lim, Lyndell L.
    Fenwick, Eva K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (13) : 5541 - 5546
  • [44] Intravitreal bevacizumab treatment for refractory diabetic macular edema
    Yuksel, Erdem
    Ozdek, Sengul
    Yuksel, Nilay
    Hasanreisoglu, Berati
    INTERNATIONAL OPHTHALMOLOGY, 2013, 33 (06) : 659 - 663
  • [45] Intravitreal bevacizumab treatment for refractory diabetic macular edema
    Oernek, Kemal
    Oernek, Nurguel
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, 24 (04) : 403 - 407
  • [46] Intravitreal bevacizumab treatment for refractory diabetic macular edema
    Erdem Yuksel
    Sengul Ozdek
    Nılay Yuksel
    Berati Hasanreisoglu
    International Ophthalmology, 2013, 33 : 659 - 663
  • [47] Intravitreal Bevacizumab for the Treatment of Refractory Diabetic Macular Edema
    Mehta, Sachin
    Blinder, Kevin J.
    Shah, Gaurav K.
    Kymes, S. M.
    Schlief, Shelley L.
    Grand, M. Gilbert
    OPHTHALMIC SURGERY LASERS & IMAGING, 2010, 41 (03) : 323 - 329
  • [48] Short-term Results of Intravitreal Dexamethasone Implant Combined with Bevacizumab versus Intravitreal Bevacizumab for Treatment-naive Diabetic Macular Edema
    Lee, Yeo Jin
    Kang, Kui Dong
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2020, 61 (12): : 1485 - 1492
  • [49] Efficacy of dexamethasone intravitreal implant in diabetic macular edema
    Bonnin, Sophie
    Dupas, Benedicte
    Perol, Julien
    Erginay, Ali
    Tadayoni, Ramin
    Massin, Pascale
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [50] Comment on "Intravitreal dexamethasone implants for diabetic macular edema"
    Calugaru, Dan
    Calugaru, Mihai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (12) : 2029 - 2030
12345